PTC Therapeutics
PTCT
#2687
Rank
NZ$10.73 B
Marketcap
NZ$133.73
Share price
-0.76%
Change (1 day)
62.53%
Change (1 year)

PTC Therapeutics (PTCT) - Total debt

Total debt on the balance sheet as of September 2025 : NZ$0.70 Billion

According to PTC Therapeutics 's latest financial reports the company's total debt is NZ$0.70 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

PTC Therapeutics - Total debt on balance sheet (from 2012 to 2025)

Total debt by year

Year Total debt Change
2024-12-31NZ$4.38 B24.3%
2023-12-31NZ$3.52 B53.12%
2022-12-31NZ$2.30 B23.87%
2021-12-31NZ$1.85 B218.93%
2020-12-31NZ$0.58 B19.63%
2019-12-31NZ$0.48 B113.52%
2018-12-31NZ$0.22 B11.75%
2017-12-31NZ$0.20 B43.96%
2016-12-31NZ$0.14 B5.66%
2015-12-31NZ$0.13 B
2014-12-31N/A-100%
2013-12-31NZ$0.05 M-99%
2012-12-31NZ$5.93 M-60.37%
2011-12-31NZ$14.97 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Vertex Pharmaceuticals
VRTX
NZ$3.17 B 347.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
NZ$2.16 B 204.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
NZ$0.13 B-80.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
NZ$86.49 M-87.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
NZ$0.11 B-83.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$55.43 B 7,707.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland